While a previous study proposed a role of RNF8 in promoting GBM tumorigenicity by mediating histone H3 ubiquitination and degradation [64], we find that RNF8 mRNA and protein levels are preferentially downregulated in gliomas, particularly those that are associated with high HER2-EGFR signaling. This evidence concerns the gene ERBB2 and central nervous system cancer.